Revenue | ₹2.68Cr |
Net Profits | ₹-1.32Cr |
Net Profit Margins | -49.25% |
Vista Pharmaceuticals Ltd’s revenue jumped 54.91% since last year same period to ₹2.68Cr in the Q3 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 7.2% jump in its revenue since last 3-months.
Vista Pharmaceuticals Ltd’s net profit jumped 19.02% since last year same period to ₹-1.32Cr in the Q3 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -36.08% fall in its net profits since last 3-months.
Vista Pharmaceuticals Ltd’s net profit margin jumped 47.72% since last year same period to -49.25% in the Q3 2024-2025. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -26.94% fall in its net profit margins since last 3-months.
The revenue for Vista Pharmaceuticals Ltd in the Q3 results 2024 was ₹2.68Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q3 results 2024 was ₹-1.32Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q3 results 2024 was -49.25%.
The revenue for Vista Pharmaceuticals Ltd in the Q3 results 2023 was ₹1.73Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q3 results 2023 was ₹-1.63Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q3 results 2023 was -94.22%.